We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
HIV treatment study clears virus, sends Sangamo stock soaring.
- Authors
Ratner, Mark
- Abstract
The article focuses on the study regarding the use of zinc finger nuclease (ZFN) for HIV treatment which appeared in the 2014 issue of "New England Journal of Medicine." Topics discussed include the increase of the share prices of Sangamo Biosciences, a company that designs a ZFN pair of proteins, targeting of C-C chemokine receptor type 5 (CCR5), and immunological approach for HIV infection control.
- Subjects
ZINC-finger proteins; HIV infections; THERAPEUTICS; NEW England Journal of Medicine, The (Periodical); STOCK prices; SANGAMO BioSciences Inc.; CHEMOKINE receptors
- Publication
Nature Biotechnology, 2014, Vol 32, Issue 5, p405
- ISSN
1087-0156
- Publication type
Article
- DOI
10.1038/nbt0514-405a